Abstract:The identification of drug-target relations (DTRs) is substantial in drug development. A large number of methods treat DTRs as drug-target interactions (DTIs), a binary classification problem. The main drawback of these methods are the lack of reliable negative samples and the absence of many important aspects of DTR, including their dose dependence and quantitative affinities. With increasing number of publications of drug-protein binding affinity data recently, DTRs prediction can be viewed as a regression problem of drug-target affinities (DTAs) which reflects how tightly the drug binds to the target and can present more detailed and specific information than DTIs. The growth of affinity data enables the use of deep learning architectures, which have been shown to be among the state-of-the-art methods in binding affinity prediction. Although relatively effective, due to the black-box nature of deep learning, these models are less biologically interpretable. In this study, we proposed a deep learning-based model, named AttentionDTA, which uses attention mechanism to predict DTAs. Different from the models using 3D structures of drug-target complexes or graph representation of drugs and proteins, the novelty of our work is to use attention mechanism to focus on key subsequences which are important in drug and protein sequences when predicting its affinity. We use two separate one-dimensional Convolution Neural Networks (1D-CNNs) to extract the semantic information of drug's SMILES string and protein's amino acid sequence. Furthermore, a two-side multi-head attention mechanism is developed and embedded to our model to explore the relationship between drug features and protein features. We evaluate our model on three established DTA benchmark datasets, Davis, Metz, and KIBA. AttentionDTA outperforms the state-of-the-art deep learning methods under different evaluation metrics. The results show that the attention-based model can effectively extract protein features related to drug information and drug features related to protein information to better predict drug target affinities. It is worth mentioning that we test our model on IC50 dataset, which provides the binding sites between drugs and proteins, to evaluate the ability of our model to locate binding sites. Finally, we visualize the attention weight to demonstrate the biological significance of the model. The source code of AttentionDTA can be downloaded from https://github.com/zhaoqichang/AttentionDTA_TCBB.

AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning with Attention Mechanism.

AttentionDTA: prediction of drug–target binding affinity using attention model

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

HyperAttentionDTI: improving drug-protein interaction prediction by sequence-based deep learning with attention mechanism

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

GTAMP-DTA: Graph transformer combined with attention mechanism for drug-target binding affinity prediction

Prediction of Drug-Target Affinity Using Attention Neural Network

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

Deep drug-target binding affinity prediction with multiple attention blocks

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

DEAttentionDTA: protein–ligand binding affinity prediction based on dynamic embedding and self-attention

Drug-Target Interaction Prediction Using Multi-Head Self-Attention and Graph Attention Network.

Drug-target Binding Affinity Prediction Model Based on Multi-Scale Diffusion and Interactive Learning

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

ColdDTA: Utilizing data augmentation and attention-based feature fusion for drug-target binding affinity prediction

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections

SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction

DeepMHADTA: Prediction of Drug-Target Binding Affinity Using Multi-Head Self-Attention and Convolutional Neural Network

DFDTA-MultiAtt: Multi-attention based deep learning ensemble fusion network for drug target affinity prediction